Skip Navigation


JAC Advance Access originally published online on February 21, 2006
Journal of Antimicrobial Chemotherapy 2006 57(4):775-779; doi:10.1093/jac/dkl040
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/4/775    most recent
dkl040v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stathi, M.
Right arrow Articles by Tzelepi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stathi, M.
Right arrow Articles by Tzelepi, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994–2004

Maria Stathi1, Alexandros Flemetakis2, Vivi Miriagou1, Helen Avgerinou2, Kyriakos P. Kyriakis1, Antonios N. Maniatis3 and Eva Tzelepi1,*

1 The National Reference Center for Neisseria gonorrhoeae, Laboratory of Bacteriology, Hellenic Pasteur Institute, Athens, Greece; 2 Microbiology Laboratory of the ‘Andreas Sygros’ Hospital for Skin and Venereal Diseases, Athens, Greece; 3 Department of Medical Microbiology, University of Thessaly, Larissa, Greece

Received 29 November 2005; returned 4 January 2006; revised and accepted 27 January 2006

* Corresponding author. Tel: +30-210-6478-810; Fax: +30-210-6423-498; E-mail: tzelepi{at}pasteur.gr

Objectives: Surveillance data concerning antimicrobial susceptibilities of Neisseria gonorrhoeae isolated in Greece during the 11 year period 1994–2004 are presented.

Methods: Antimicrobial susceptibilities of all gonococcal isolates received by the Greek National Reference Center for N. gonorrhoeae during the study period were determined in terms of MICs using Etest. Trends in yearly isolation frequencies by susceptibility category were estimated for defining significant changes in overall susceptibility figures.

Results: Cefotaxime and spectinomycin retained undiminished activity against all isolates throughout the study period. High rates of resistance and intermediate susceptibilities were noticed for penicillin, tetracycline and erythromycin, and even for norfloxacin and ciprofloxacin. A substantial portion (16.5%) of the gonococcal samples consisted of multiresistant strains exhibiting resistance to two or more agents of different antibiotic classes. Although annual rates of low-level chromosomal resistance decreased, high-level resistance owing to the presence of penicillin- and tetracycline-resistance plasmids increased. Fluoroquinolone resistance also showed a significant increasing trend after 1996, reaching a peak rate of 11.3% in 2004.

Conclusion: Third-generation cephalosporins and spectinomycin should be considered as first-choice drugs for the empirical treatment of gonorrhoea in Greece.

Keywords: N. gonorrhoeae , gonorrhoea , antibiotic resistance , fluoroquinolones


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
J. W. Tapsall, E. A. Limnios, D. Murphy, and on behalf of the Australian Gonococcal Surveillanc
Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006
J. Antimicrob. Chemother., January 1, 2008; 61(1): 150 - 155.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Bala, K. Ray, S. M. Gupta, S. Muralidhar, and R. K. Jain
Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains
J. Antimicrob. Chemother., September 1, 2007; 60(3): 582 - 586.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. M. C. Martin, S. Hoffmann, C. A. Ison, and on behalf of the European Surveillance of Sexually
European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe
J. Antimicrob. Chemother., September 1, 2006; 58(3): 587 - 593.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.